Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery

MS Alavijeh, M Chishty, MZ Qaiser, AM Palmer - NeuroRx, 2005 - Springer
The worldwide market for therapies for CNS disorders is worth more than $50 billion and is
set to grow substantially in the years ahead. This is because: 1) the incidence of many CNS …
被引用次数：605 相关文章

Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery

MS Alavijeh, M Chishty, MZ Qaiser, AM Palmer - Neurotherapeutics, 2005 - infona.pl
The worldwide market for therapies for CNS disorders is worth more than $50 billion and is
set to grow substantially in the years ahead. This is because: 1) the incidence of many CNS …
[HTML] nih.gov

[HTML][HTML] Drug Metabolism and Pharmacokinetics, the Blood-Brain Barrier, and Central Nervous System Drug Discovery

MS Alavijeh, M Chishty, MZ Qaiser, AM Palmer - NeuroRx, 2005 - ncbi.nlm.nih.gov
The worldwide market for therapies for CNS disorders is worth more than $50 billion and is
set to grow substantially in the years ahead. This is because: 1) the incidence of many CNS …

Drug Metabolism and Pharmacokinetics, the Blood-Brain Barrier, and Central Nervous System Drug Discovery

MS Alavijeh, M Chishty, MZ Qaiser… - …, 2005 - neurotherapeuticsjournal.org
The worldwide market for therapies for CNS disorders is worth more than $50 billion and is
set to grow substantially in the years ahead. This is because: 1) the incidence of many CNS …

Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery

MS Alavijeh, M Chishty, MZ Qaiser… - …, 2005 - search.proquest.com
The worldwide market for therapies for CNS disorders is worth more than $50 billion and is
set to grow substantially in the years ahead. This is because: 1) the incidence of many CNS …

Drug Metabolism and Pharmacokinetics, the Blood-Brain Barrier, and Central Nervous System Drug Discovery

MS Alavijeh, M Chishty, MZ Qaiser, AM Palmer - NeuroRX, 2005 - Elsevier
The worldwide market for therapies for CNS disorders is worth more than $50 billion and is
set to grow substantially in the years ahead. This is because: 1) the incidence of many CNS …

[引用][C] Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery

MS Alavijeh, M Chishty, MZ Qaiser, AM Palmer - NeuroRX, 2005 - cir.nii.ac.jp
Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system
drug discovery | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.

MS Alavijeh, M Chishty, MZ Qaiser… - Neurorx: the Journal of …, 2005 - europepmc.org
The worldwide market for therapies for CNS disorders is worth more than $50 billion and is
set to grow substantially in the years ahead. This is because: 1) the incidence of many CNS …

Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery

MS Alavijeh, M Chishty, MZ Qaiser… - NeuroRx: the journal …, 2005 - pubmed.ncbi.nlm.nih.gov
The worldwide market for therapies for CNS disorders is worth more than 50 billion dollars
and is set to grow substantially in the years ahead. This is because: 1) the incidence of many …

Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery.

MS Alavijeh, M Chishty, MZ Qaiser… - Neurorx: the Journal of …, 2005 - europepmc.org
The worldwide market for therapies for CNS disorders is worth more than $50 billion and is
set to grow substantially in the years ahead. This is because: 1) the incidence of many CNS …